Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus
Condition:   Cutaneous Lichen Planus Intervention:   Drug: Baricitinib (LY3009104) Sponsor:   Aaron R. Mangold Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2022 Category: Research Source Type: clinical trials